Cancer 
        Digest        

A new cost/benefit analysis of an immunotherapy drug that showed significantly longer survival for people with an aggressive form of lung cancer, called small-cell lung cancer, concludes that the treatment might be too expensive to be worth it.

Short intensive periods of physical activity can unleash several molecules in the blood linked to reducing inflammation and improving blood vessel function and metabolism, which can slow colorectal cancer growth.

Alyssa Tapley was the first patient to undergo a new gene therapy called BE-CAR7 for her T-cell acute lymphoblastic leukemia, a previously untreatable form of cancer. She has been cancer-free for more than three years. (Image credit – University College of London) CANCER DIGEST – Dec. 27, 2025 – Using a more precise genetic editing technique researchers at the University College of Lindon, in the United Kingdom have developed an advanced form of CAR-T cell therapy that has el

Patients with a rare skin cancer who received an immunotherapy drug after surgery had a 42 percent lower risk of the cancer spreading to other parts of the body.

Women under 50 are being diagnosed with cancer more often than screening guidelines predict, with a large percentage of these cancers being invasive and harder to treat.

Lung cancer patients who received COVID-19 vaccination survived nearly twice as long as similar patients who did not get the vaccine, a new observational study shows.